1-8 of 8
M. Fisher
Close
Sort by
Journal Articles

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation

Sung W. Choi, Gerhard C. Hildebrandt, Krystyna M. Olkiewicz, David A. Hanauer, Meghana N. Chaudhary, Ines A. Silva, Clare E. Rogers, Daphne T. Deurloo, Jacki M. Fisher, Chen Liu, David Adams, Stephen W. Chensue, Kenneth R. Cooke
Journal: Blood
Blood (2007) 110 (9): 3447–3455.
https://doi.org/10.1182/blood-2007-05-087403
Published: 2007
Journal Articles

Secondary Lymphoid Tissues Are Not Required for the Induction of GVHD Following Allogeneic BMT: A Shifting Paradigm for T Cell Allo-Activation.

Ines A. Silva, MS, Krystyna Olkiewicz, Jacquelyn M. Fisher, BS, Meghana N. Chaudhary, MS, Kevin Vannella Vannella, MS, Daphne T. Deurloo, PhD, Sung W. Choi, MD, Chen Liu, MD, Kenneth R. Cooke, MD
Journal: Blood
Blood (2006) 108 (11): 3170.
https://doi.org/10.1182/blood.V108.11.3170.3170
Published: 2006
Journal Articles

Bortezomib (Velcade) When Given Pretransplant and Once Weekly as Consolidation Therapy Following High Dose Chemotherapy (HDCT) Leads to High Rates of Reactivation of Varicella Zoster Virus (VZV).

Shachar Peles, MD, Nicholas M. Fisher, Steven M. Devine, MD, Michael H. Tomasson, MD, John F. DiPersio, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2005) 106 (11): 3237.
https://doi.org/10.1182/blood.V106.11.3237.3237
Published: 2005
Journal Articles

Once Weekly Bortezomib (Velcade) Preserves Bone Health by a Direct Effect on Osteoclast Function Independent of Its Effect on the Malignant Plasma Cells.

Shachar Peles, MD, Nicholas M. Fisher, Feng Gao, MD, PhD, Steven M. Devine, Michael H. Tomasson, MD, John F. DiPersio, MD, PhD, Ravi Vij, MD.
Journal: Blood
Blood (2005) 106 (11): 3458.
https://doi.org/10.1182/blood.V106.11.3458.3458
Published: 2005
Journal Articles

Bortezomib Does Not Impair Cytokine Induced Mobilization of Stem Cells Prior to Autologous Transplantation in Multiple Myeloma.

Geoffrey L. Uy, MD, Nicholas M. Fisher, BS, Steven M. Devine, M.D, Michael H. Tomasson, MD, John F. DiPersio, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2005) 106 (11): 2926.
https://doi.org/10.1182/blood.V106.11.2926.2926
Published: 2005
Journal Articles

Bortezomib Alters Peripheral Blood Lymphocyte Subsets in Patients with Multiple Myeloma.

Geoffrey L. Uy, MD, Matthew S. Holt, BS, Nicholas M. Fisher, BA, Steven M. Devine, MD, Michael H. Tomasson, MD, John F. DiPersio, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2005) 106 (11): 2387.
https://doi.org/10.1182/blood.V106.11.2387.2387
Published: 2005
Journal Articles

Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Geoffrey L. Uy, M.D., Nicholas M. Fisher, B.S., Steven M. Devine, M.D., Hanna J. Khoury, M.D, Douglas R. Adkins, M.D., Michael H. Tomasson, M.D, Timothy A. Graubert, M.D., John F. DiPersio, M.D., Ph.D., Ravi Vij, M.D.
Journal: Blood
Blood (2004) 104 (11): 541.
https://doi.org/10.1182/blood.V104.11.541.541
Published: 2004
Journal Articles

Endothelin-1 Induces Production of the Neutrophil Chemotactic Factor Interleukin-8 by Human Brain-Derived Endothelial Cells

F.M. Hofman, P. Chen, R. Jeyaseelan, F. Incardona, M. Fisher, R. Zidovetzki
Journal: Blood
Blood (1998) 92 (9): 3064–3072.
https://doi.org/10.1182/blood.V92.9.3064
Published: 1998